State Street SPDR S&P Biotech ETF (XBI) Stock Price, Quote, News & History

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD83,764.20+1.01%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Premium

State Street SPDR S&P Biotech ETF (XBI) Stock Price, Quote, News & History

XBIARCA

Trade with Public

$153.75

4.462.99%

Last update: Oct 9, 7:52 PM

$153.85

4.563.05%

OverviewNews Holdings Dividends Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

10.30B

Fund Score

Key Statistics

Open

$149.32

High

$153.85

52 Wk High

$169.89

AUM

10.30B

Dividend

$0.58

Ex-Div Date

Jun 22, 2026

Volume

12.14M

Market Cap

$19.44B

Mgmt Fee

0.35%

P/E Ratio

17.02

Prev. Close

$149.29

Low

$153.85

52 Wk Low

$103.43

Shares Out

75.22M

Yield

0.38%

Div. Freq

Avg. Volume Daily

9.14M

Beta

0.83

Avg. Expense Ratio

0.35%

P/B Ratio

4.82

Recent SPDR Series Trust - SPDR S&P Biotech ETF News

Nasdaq 100 Climbs as Cooler PCE Cuts Rate Hike Bets, Micron Earnings Loom: Stock Market Today

Nasdaq 100 gains as softer PCE inflation cools Fed rate-hike bets, with oil above $91 and Micron earnings due after the bell Wednesday.

Piero Cingari

Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach

B. Riley sees 40+ biotech catalysts ahead as rising rates pressure XBI, setting up a key test for the sector during the Q3 2026 earnings season.

Chandrima Sanyal

Economy Grows 63% in Six Years, 30-Year Treasury Lost Almost As Much

Over six years, U.S. nominal GDP rose 63% while the 30-year Treasury fell 60%. Are investors positioned for a surge in stocks and yields?

Piero Cingari

Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets

Cathie Wood’s ARKG bought Ionis, Beam, Veracyte and Scribe Therapeutics. Here are the biotech ETFs that also hold her latest bets.

Chandrima Sanyal

Healthcare ETFs Were Left Behind. JPMorgan Sees the Money Coming Back

JPMorgan sees healthcare ETF flows reversing, with Eli Lilly and AbbVie among stocks that could benefit from renewed sector rotation.

Chandrima Sanyal

FAQ

How do I buy State Street SPDR S&P Biotech ETF (XBI) stock?

You can purchase shares of State Street SPDR S&P Biotech ETF (ARCA:XBI) through any online brokerage.

View our list of the best stock brokerages

Who are State Street SPDR S&P Biotech ETF (XBI) competitors?

There are no as such competitors for State Street SPDR S&P Biotech ETF.

What is the forecast, or price target, for State Street SPDR S&P Biotech ETF (XBI) stock?

There is no analysis for State Street SPDR S&P Biotech ETF to provide a consensus price target.

What is the current price for State Street SPDR S&P Biotech ETF (XBI)?

The stock price for State Street SPDR S&P Biotech ETF (ARCA: XBI) is $153.85 last updated October 9, 2026 at 7:52 PM EDT.

Does State Street SPDR S&P Biotech ETF (XBI) pay a dividend?

There are no upcoming dividends for State Street SPDR S&P Biotech ETF.

When is State Street SPDR S&P Biotech ETF (ARCA:XBI) reporting earnings?

State Street SPDR S&P Biotech ETF does not have any upcoming earnings scheduled.

Is State Street SPDR S&P Biotech ETF (XBI) going to split?

There is no upcoming split for State Street SPDR S&P Biotech ETF.

Key Statistics

Open

$149.32

High

$153.85

52 Wk High

$169.89

AUM

10.30B

Dividend

$0.58

Ex-Div Date

Jun 22, 2026

Volume

12.14M

Market Cap

$19.44B

Mgmt Fee

0.35%

P/E Ratio

17.02

Prev. Close

$149.29

Low

$153.85

52 Wk Low

$103.43

Shares Out

75.22M

Yield

0.38%

Div. Freq

Avg. Volume Daily

9.14M

Beta

0.83

Avg. Expense Ratio

0.35%

P/B Ratio

4.82

About State Street SPDR S&P Biotech ETF

Sector

N/A

Industry

N/A

ETF Details

Sector	Healthcare
Category	Mid Performer-Mid Growth
Investment Style	Small Cap Blend
Fund Inception	Jan 31, 2006
Managers	Raymond Donofrio Karl A. Schneider
Definition	Most of the stocks in this equity fund have average financial performance and average growth potential

Investment Policy

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).

Top ETF Holdings

Symbol	Name	Share %
TWST	Twist Bioscience Corp.	1.82%
KYMR	Kymera Therapeutics In...	1.43%
RVMD	Revolution Medicines I...	1.37%
ORKA	Oruka Therapeutics Inc...	1.40%
MRNA	Moderna Inc	3.04%
HALO	Halozyme Therapeutics ...	1.48%
NTRA	Natera Inc	1.48%
BM	Roivant Sciences Ltd. ...	1.39%
TVTX	Travere Therapeutics I...	1.37%
INSM	Insmed Inc	1.37%

Key Statistics

Open

$149.32

High

$153.85

52 Wk High

$169.89

AUM

10.30B

Dividend

$0.58

Ex-Div Date

Jun 22, 2026

Volume

12.14M

Market Cap

$19.44B

Mgmt Fee

0.35%

P/E Ratio

17.02

Prev. Close

$149.29

Low

$153.85

52 Wk Low

$103.43

Shares Out

75.22M

Yield

0.38%

Div. Freq

Avg. Volume Daily

9.14M

Beta

0.83

Avg. Expense Ratio

0.35%

P/B Ratio

4.82

Recent SPDR Series Trust - SPDR S&P Biotech ETF News

Nasdaq 100 Climbs as Cooler PCE Cuts Rate Hike Bets, Micron Earnings Loom: Stock Market Today

Nasdaq 100 gains as softer PCE inflation cools Fed rate-hike bets, with oil above $91 and Micron earnings due after the bell Wednesday.

Piero Cingari

Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach

B. Riley sees 40+ biotech catalysts ahead as rising rates pressure XBI, setting up a key test for the sector during the Q3 2026 earnings season.

Chandrima Sanyal

Economy Grows 63% in Six Years, 30-Year Treasury Lost Almost As Much

Over six years, U.S. nominal GDP rose 63% while the 30-year Treasury fell 60%. Are investors positioned for a surge in stocks and yields?

Piero Cingari

Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets

Cathie Wood’s ARKG bought Ionis, Beam, Veracyte and Scribe Therapeutics. Here are the biotech ETFs that also hold her latest bets.

Chandrima Sanyal

Healthcare ETFs Were Left Behind. JPMorgan Sees the Money Coming Back

JPMorgan sees healthcare ETF flows reversing, with Eli Lilly and AbbVie among stocks that could benefit from renewed sector rotation.

Chandrima Sanyal

FAQ

How do I buy State Street SPDR S&P Biotech ETF (XBI) stock?

You can purchase shares of State Street SPDR S&P Biotech ETF (ARCA:XBI) through any online brokerage.

View our list of the best stock brokerages

Who are State Street SPDR S&P Biotech ETF (XBI) competitors?

There are no as such competitors for State Street SPDR S&P Biotech ETF.

What is the forecast, or price target, for State Street SPDR S&P Biotech ETF (XBI) stock?

There is no analysis for State Street SPDR S&P Biotech ETF to provide a consensus price target.

What is the current price for State Street SPDR S&P Biotech ETF (XBI)?

The stock price for State Street SPDR S&P Biotech ETF (ARCA: XBI) is $153.85 last updated October 9, 2026 at 7:52 PM EDT.

Does State Street SPDR S&P Biotech ETF (XBI) pay a dividend?

There are no upcoming dividends for State Street SPDR S&P Biotech ETF.

When is State Street SPDR S&P Biotech ETF (ARCA:XBI) reporting earnings?

State Street SPDR S&P Biotech ETF does not have any upcoming earnings scheduled.

Is State Street SPDR S&P Biotech ETF (XBI) going to split?

There is no upcoming split for State Street SPDR S&P Biotech ETF.

Key Statistics

Open

$149.32

High

$153.85

52 Wk High

$169.89

AUM

10.30B

Dividend

$0.58

Ex-Div Date

Jun 22, 2026

Volume

12.14M

Market Cap

$19.44B

Mgmt Fee

0.35%

P/E Ratio

17.02

Prev. Close

$149.29

Low

$153.85

52 Wk Low

$103.43

Shares Out

75.22M

Yield

0.38%

Div. Freq

Avg. Volume Daily

9.14M

Beta

0.83

Avg. Expense Ratio

0.35%

P/B Ratio

4.82

About State Street SPDR S&P Biotech ETF

Sector

N/A

Industry

N/A

ETF Details

Sector	Healthcare
Category	Mid Performer-Mid Growth
Investment Style	Small Cap Blend
Fund Inception	Jan 31, 2006
Managers	Raymond Donofrio Karl A. Schneider
Definition	Most of the stocks in this equity fund have average financial performance and average growth potential

Investment Policy

Top ETF Holdings

Symbol	Name	Share %
TWST	Twist Bioscience Corp.	1.82%
KYMR	Kymera Therapeutics In...	1.43%
RVMD	Revolution Medicines I...	1.37%
ORKA	Oruka Therapeutics Inc...	1.40%
MRNA	Moderna Inc	3.04%
HALO	Halozyme Therapeutics ...	1.48%
NTRA	Natera Inc	1.48%
BM	Roivant Sciences Ltd. ...	1.39%
TVTX	Travere Therapeutics I...	1.37%
INSM	Insmed Inc	1.37%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

10.30B

Fund Score